Target intelligence / Profile preview

Ebola virus glycoprotein GP2 stalk-membrane proximal external region (EBOV GP2 stalk-MPER)

Target
EBOV GP2 stalk-MPER
Molecular classification
Viral envelope protein, Class I viral fusion protein
01

Overview

The Ebola virus glycoprotein (GP) is a class I fusion protein that mediates viral entry into host cells. It exists as a trimer of GP1 and GP2 heterodimers, where GP1 is responsible for receptor binding and GP2 facilitates membrane fusion (Bornholdt et al., 2016, Science 351:1078). The stalk and membrane proximal external region (MPER) of GP2 are located near the viral membrane and play a crucial role in the conformational changes that drive the fusion of the viral envelope with the host endosomal membrane (Wec et al., 2017, Science 357:1034). This region is highly conserved among various ebolaviruses, making it an attractive target for the development of broadly neutralizing antibodies (bnAbs) and universal vaccines (King et al., 2019, Nature Microbiology 4:1304). Drugs or antibodies targeting the GP2 stalk-MPER typically function by sterically hindering the transition from the pre-fusion to the post-fusion state, thereby blocking viral infection (UniProtKB - P87666). Because of its conservation, targeting this site may provide protection against multiple species within the Ebolavirus genus.

Other names
Ebola virus GP2 stalkEbola virus GP2 MPEREBOV GP2 membrane proximal external regionGP2 stalk-MPER domain
02

Mechanism of action

Inhibition of the conformational transition from pre-fusion to post-fusion states of the GP2 subunit, thereby blocking the fusion of the viral envelope with the host endosomal membrane.

03

Biological functions

Viral entryMembrane fusionViral attachment
04

Disease associations

Ebola virus diseaseInfection
05

Safety considerations

Viral mutational escapePotential for antibody-dependent enhancement (ADE)Therapeutic delivery challenges during acute infection
06

Interacting drugs

ADI-15878

5 more in the full profile.

07

Biomarkers

Ebola virus RNA (viral load)GP2-specific neutralizing antibody titers

Beyond the preview

Go deeper on Ebola virus glycoprotein GP2 stalk-membrane proximal external region (EBOV GP2 stalk-MPER).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ebola virus glycoprotein GP2 stalk-membrane proximal external region (EBOV GP2 stalk-MPER).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call